Although in the present study the upregulation of CD2 was not associated with survival, testing this antibody may be significant for the treatment of pancreatic cancer since it provides novel insights into immunotherapy.
← all excerpts
Mass spectrum analysis of membrane proteins reveals that CASK, CD36 and EPB42 are differentially expressed in pancreatic adenocarcinoma.
1
—
—